Nick Delmonico, Cofounder and CEO of Strados Labs presented live at ATA 2023 on March 6th in San Antonio, TX and was named a winner in the ‘Tools that Deliver Care’ category.
Philadelphia, PA March 8, 2023 – Strados Labs today announced that it was named a winner in the ATA Telehealth Innovators Challenge as part of the ‘Tools That Deliver Care’ category. Strados was recognized for its RESP™ Biosensor, a device similar to a wearable stethoscope that captures lung sounds and tracks events like cough and wheeze for care teams to monitor.
Twelve finalists were selected from a field of 40 companies that made it through the first round of judging, representing four key digital and telehealth solution categories. The 12 finalists presented their innovations in a live pitch competition on the main stage at ATA 2023:
“At Strados our goal is to improve access to diagnostic care for the thousands of people suffering from advanced pulmonary diseases such as COPD and Asthma,” said Strados CEO Nick Delmonico. “We are thrilled to be recognized by the American Telemedicine Association as part of this challenge along with other companies leading the way in telehealth.”
“When the ATA launched the first Telehealth Innovators Challenge last year, we did not anticipate the overwhelming response it would receive from leaders in virtual care at every level,” said Samir Batra, Founder and CEO, BAHA Enterprises, and Advisor and Emcee of the ATA Telehealth Innovators Challenge. “The Innovators Challenge has instantly become the premier platform to introduce the most exciting new innovations in virtual care and the companies selected to participate represent the best of the best in setting new standards in telehealth technology and service delivery.”
A panel of industry leaders representing all areas of virtual care served as judges for the Innovators Challenge and selected the final winners during the live pitch competition at ATA 2023. ATA 2023 was held March 4-6, 2023, at the Henry B. González Convention Center in San Antonio, Texas.
About Strados Labs
Strados Labs, a medical technology company harnessing the power of machine learning, is the developer of the RESP Biosensor: an FDA-cleared and CE marked wearable device that allows for remote monitoring of lung sounds such as cough, wheeze, rhonchi, and rales as well as other vitals and functions. The technology provides clinicians with remote insight into a patient’s worsening respiratory disease allowing for earlier intervention. The RESP biosensor is also used in clinical trials to support the development of new therapies. The company is based in Philadelphia and is privately owned.